Sevirumab

Sevirumab (MSL-109) is a human IgG1 neutralizing monoclonal antibody against cytomegalovirus (CMV). Sevirumab recognizes CMV gH complexes and inhibits CMV replication with an EC50 of 0.3 μg/mL.
Read more
€0.00 (tax incl.)
Reference:
HY-P99900
Product Details
HY-P99900

Data sheet

Size
Multiple sizes
Reactivity
CMV
CAS
138660-96-5

Menu

Settings